Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'

CNBC's Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.

from Health and Science https://ift.tt/i3z2bXG
https://ift.tt/kboZXEs
https://ift.tt/8R7Xagn